Our findings support the idea to perform assays of BNP and other biomarkers, such as creatine kinase, cardiac troponin I, heart-type fatty acid-binding protein, adrenomedullin, and osteoprotegerin, in combination with imaging analysis as a tool for differential diagnosis and therapy in heart diseases [57,58]. This evidence concerns the gene ADM and heart disorder.